Business Wire

Sensor Electronic Technology Obtains Permanent Injunction Against U.S. UV LED Companies

Share

Sensor Electronic Technology, Inc. (“SETi”), a leading global innovator of deep UV LED products and technology, announced that it successfully obtained a permanent injunction in a patent infringement lawsuit against Bolb, Inc. (“Bolb”), and Quantum Egg, Inc. (“Q-Egg”).

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20191205005031/en/

To view this piece of content from mms.businesswire.com, please give your consent at the top of this page.

The history of UV LED business (Graphic: Business Wire)

The California Northern District federal court issued a permanent injunction against the sales of an accused UV LED sterilizer device, as well as any mere colorable variations, according to the parties’ stipulation. The Court will therefore prohibit the sale of similar products if they prove to be mere colorable variations of the accused products.

The asserted patents in this litigation cover fundamental UV LED technology, encompassing UV LED sterilizer structures and drivers, chip fabrication, and epitaxial layer growth.

Bolb is a UV LED company co-founded by former SETi employees, and Q-Egg was the distributor of the accused UV LED sterilizer device.

The UV LED market has expanded to a range of fields, including air and water purification devices, as well as medical and bio devices for skin care. The UV LED market value will grow up to $1.2 billion in 2022 according to a market report from LEDinside (2018).

SETi has also collaborated with South Korean UV LED company Seoul Viosys Co., Ltd. (“SVC”), resulting in the development of Violeds technology for UV LED-based disinfection, deodorization, phototherapy and curing. Violeds technology has been used by the US National Aeronautics and Space Administration (NASA) aboard the International Space Station (ISS). SETi also supplies UV LED products to America’s largest heating and cooling manufacturing brand company. This product has been recognized by customers for its high performance in sterilizing various bacteria that live inside air conditioner equipment and preventing it from spreading inside a home or office during operation.

“It is difficult to survive on a long-term basis in the UV LED industry without a strong foundation in intellectual property and technology expertise, something that SETi and SVC have gained thanks to their extensive investment in research and development,” said Chae Hon Kim, CEO of SETi.

“SETi believes in furthering a market of fair competition and investment in intellectual property. We believe that this rewards research and development, allowing entrepreneurs and small businesses to have their hard work recognized in the marketplace. We also believe in the importance of green technology. As a UV LED pioneer developing commercialized UV LED for the first time in the word, we plan to make our products available at even more competitive pricing to encourage the distribution of our green technology products in the market, thereby contributing to a clean and healthy environment,” added Kim.

Semicon Light Co, Ltd., an investor of Bolb, did sales promotion for the accused UV LED and sterilizer device UV LEDs in Japan and other countries.

About SETi

Sensor Electronic Technology, inc. (SETi), a division of Seoul Semiconductor (KOSDAQ 046890) and Seoul Viosys, is the world’s leading supplier of deep UV LEDs (emission wavelengths shorter than 340nm), as well as a broad portfolio of UV-B, and UV-C LED products and application solutions. SETi UV LEDs are certified to AS9100D with ISO 9001:2015, and the company is committed to meeting and exceeding the needs of customers and stakeholders through the highest level of quality management. To learn more, visit http://www.s-et.com/en/.

About Seoul Viosys

Seoul Viosys is the world’s first UV LED solution provider. Established in 2002 as a subsidiary of Seoul Semiconductor, the company developed EPI, FAB, and UV LEDs. In 2005, it produced UVC LEDs of 275nm, 310nm and 340nm for the first time in the world. In 2007, it achieved mass production of Deep UV LEDs for 255nm~340nm and has become the only company to produce UV LEDs of all wavelengths. Seoul Viosys has more than 6,000 patents related to UV LED technology. Its UV LED modules provide strong sterilization and disinfection (UVC), skin regeneration (UVB) and effective cultivation for horticulture. It is an eco-friendly and healthy product with no harmful chemicals unlike conventional mercury lamps. The key products have been applied to applications for water/air purification and sterilization are opening new application possibilities for horticulture, residential, commercial, water treatment facilities, health care, and even automobiles. To learn more, visit http://www.seoulviosys.com/en/.

To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.

Contact information

Sensor Electronic Technology, Inc.
Francis Jung
+1-803-647-9757 (155)
fjung@s-et.com

About Business Wire

For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

Mundipharma acquires all assets and rights related to REZZAYO® (rezafungin), reinforcing continued commitment to management of infectious diseases and specialty care therapeutic area24.4.2024 23:01:00 EEST | Press release

Mundipharma* today announced the acquisition of all assets and rights related to rezafungin globally from Cidara Therapeutics. This provides Mundipharma with global ownership of rezafungin including ongoing development and distribution. Rezafungin is a novel once-weekly echinocandin indicated for the treatment of invasive candidiasis in adults.1 Invasive candidiasis, is a severe, life-threatening infection of the bloodstream and/or deep/visceral tissues.2,3 It affects seriously ill people, especially those with a weakened immune system and the mortality rate can be 40%4 or more.5,6 It can place a large burden on the healthcare system, with the potential for extended treatment regimens and long hospital stays.6 Over the last 15 years, there have been no new treatments and morbidity and mortality rates remain largely the same, indicating the need for alternative treatment options.7,8 “This acquisition places Mundipharma in the best position to realise the full potential of rezafungin inc

Global Oncology Innovator BeiGene Highlights New Data across Hematology and Solid Tumor Portfolio at 2024 ASCO Annual Meeting24.4.2024 23:01:00 EEST | Press release

BeiGene, Ltd. (NASDAQ: BGNE; HKEX: 06160; SSE: 688235), a global oncology company, today announced it will share research outcomes from its broad hematology and solid tumor portfolio at the American Society of Clinical Oncology (ASCO) Annual Meeting in Chicago, May 31 - June 4, 2024. “Our presentations at this year’s ASCO highlight the strength of our growing oncology portfolio and our commitment to developing treatments that address the unmet needs of patients with B-cell malignancies and solid tumors,” Mehrdad Mobasher, M.D., M.P.H., Chief Medical Officer, Hematology at BeiGene. “The exciting data we will share during ASCO showcase BRUKINSA’s uniquely differentiated clinical profile and add to the growing body of evidence supporting its role across the blood cancer treatment paradigm.” BeiGene will share new data for BRUKINSA (zanubrutinib), which add to the robust efficacy and safety evidence differentiating it within the BTK class. Key highlights include: A network meta-analysis co

TSMC Celebrates 30th North America Technology Symposium with Innovations Powering AI with Silicon Leadership24.4.2024 22:30:00 EEST | Press release

TSMC (TWSE: 2330, NYSE: TSM) today unveiled its newest semiconductor process, advanced packaging, and 3D IC technologies for powering the next generation of AI innovations with silicon leadership at the Company’s 2024 North America Technology Symposium. TSMC debuted the TSMC A16TM technology, featuring leading nanosheet transistors with innovative backside power rail solution for production in 2026, bringing greatly improved logic density and performance. TSMC also introduced its System-on-Wafer (TSMC-SoW™) technology, an innovative solution to bring revolutionary performance to the wafer level in addressing the future AI requirements for hyperscaler datacenters. This year marks the 30th anniversary of TSMC’s North America Technology Symposium, and more than 2,000 attended the event, growing from less than 100 attendees 30 years ago. The North America Technology Symposium in Santa Clara, California kicks off TSMC Technology Symposiums around the world in the coming months. The symposiu

Rimini Street Appoints Steve Hershkowitz as Chief Revenue Officer24.4.2024 19:50:00 EEST | Press release

Rimini Street, Inc. (Nasdaq: RMNI), a global provider of end-to-end enterprise software support, products, and services, the leading third-party support provider for Oracle and SAP software, and a Salesforce and AWS partner, today announced the appointment of Steve Hershkowitz as its new Chief Revenue Officer (CRO). This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20240424061249/en/ Rimini Street Appoints Steve Hershkowitz as Chief Revenue Officer (Photo: Business Wire) “Steve’s leadership and extensive experience scaling businesses to deliver top-line growth will expand our sales reach to capture new logos and increase our opportunity to provide even greater value to our clients,” said Rimini Street president and CEO Seth Ravin. “The global revenue team and I are excited to work closely together with Steve to drive growth and broader capabilities for our company.” Leading the Next Chapter of Sales Growth and Continued Success f

Hithium Hosts Roundtable at the BNEF Summit New York, Discussing Next Generation Battery Energy Storage System24.4.2024 19:00:00 EEST | Press release

From April 16th to 17th, the BloombergNEF (BNEF) Summit was held in New York, USA. The BNEF Summit brings together energy, finance, and technology professionals to facilitate the exchange of ideas, insights, and connections. This was Hithium's first time attending after its global launch in 2023. Hithium was also invited to host a roundtable discussion on the topic of "Next Generation Battery Energy Storage System: Latest Technology Trends and Impact on Project Economics," led by Hithium Director of Global Applications Engineering, Neil Bradshaw. The discussion focused on the future development trends of energy storage and included insights on Hithium's technology innovations, global application practices, and international development for global energy green transformation. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20240423336349/en/ BNEF summit roundtable hosted by HiTHIUM (Photo: Business Wire) Hithium’s advantages on

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
HiddenA line styled icon from Orion Icon Library.Eye